SOLICITATION NOTICE
66 -- Whole Body Plethysmography System for Animal Subjects - Combined Synopsis Solicitation NIHDA201800497
- Notice Date
- 8/24/2018
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211, MSC 9559, Bethesda, Maryland, 20892-9559, United States
- ZIP Code
- 20892-9559
- Solicitation Number
- NIHDA201800497
- Archive Date
- 9/13/2018
- Point of Contact
- Kenneth V Janosko, Phone: 3014436677
- E-Mail Address
-
kenneth.janosko@nih.gov
(kenneth.janosko@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Combined Synopsis Solicitation NIHDA201800497 This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a separate written solicitation will not be issued. The solicitation number is NIHDA201800497 and the solicitation is issued as a Request for Quotation (RFQ). This procurement is unrestricted. This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. A fixed-price type of purchase order is contemplated for this requirement. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-98 / 05/31/18 The North American Industry Classification System (NAICS) code for this procurement is 334516 - Analytical Laboratory Instrument Manufacturing with associated small business size standard of 1000 employees. Background: The Neurobiology of Addiction Section (NAS) of the Integrative Neuroscience Research Branch (INRB), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) seeks to understand how cellular and molecular changes produce changes in particular neurocircuits to convey negative emotional states that contribute to the motivation to seek drugs. The NAS is examining drug dependence as a complex psychiatric condition characterized by craving, compulsive drug seeking, excessive drug taking, and the emergence of negative emotional states during withdrawal. With the opioid epidemic recently declared a public health emergency due to the unprecedented high levels of opioid-related overdose deaths, NAS is working to test currently approved medications for opioid dependence. There are medications approved for the treatment of opioid addiction. However, it is unknown whether these medications protect or make it worse if an individual relapses to drug taking. In order to examine these effects, a whole-body plethysmography system is required to currently approved medications for opioid dependence as well as novel medications for their potential to block or reverse respiratory depression caused by opioids. Purpose and Objective: This is a request for one whole body plethysmography system. The system will allow NIDA to study the causes of opioid overdose deaths by comparing the effects of currently approved drugs to treat opioid dependence on opioid-induced overdose deaths and studying the potential effects of novel compounds in reversing opioid-induced respiratory depression. See the attached combined/synopsis document for a full description, including instructions.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/NIHDA201800497/listing.html)
- Record
- SN05056088-W 20180826/180824231652-157a3e4fe66acd4d58d8a98a9c206f72 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |